Back to Search
Start Over
A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic
- Source :
- The Lancet Oncology, The Lancet. Oncology
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
- Subjects :
- 2019-20 coronavirus outbreak
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Pneumonia, Viral
Risk-based testing
Antiviral Agents
Risk Assessment
Article
Betacoronavirus
Neoplasms
Pandemic
Medicine
Humans
Intensive care medicine
Pandemics
Royaume uni
Data Management
Clinical Trials, Phase I as Topic
business.industry
SARS-CoV-2
COVID-19
United Kingdom
Clinical trial
Oncology
Risk assessment
business
Early phase
Coronavirus Infections
Subjects
Details
- Language :
- English
- ISSN :
- 14702045
- Database :
- OpenAIRE
- Journal :
- The Lancet Oncology
- Accession number :
- edsair.doi.dedup.....faa2567af16254fd2e82769254936a74
- Full Text :
- https://doi.org/10.1016/s1470-2045(20)30339-9